Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Chromatography
6.2 X-Ray Crystallography
6.3 Protein Microarray
6.4 Spectroscopy
Chapter 7 Market Segmentation by Services
7.1 Data Analysis & Maintenance
7.2 Quantitation Services
7.3 Analytical Laboratory Services
Chapter 8 Market Segmentation by Application
8.1 Drug Discovery
8.2 Clinical Diagnosis
8.3 Others
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 Spain
9.2.3 UK
9.2.4 France
9.2.5 Russia
9.2.6 Italy
9.2.7 Others
9.3 Asia Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia
9.3.6 Others
9.4 The Middle East and Africa
9.4.1 Introduction
9.4.2 South Africa
9.4.3 Middle East Countries
9.4.4 Others
9.5 South America
9.5.1 Introduction
9.5.2 Argentina
9.5.3 Brazil
9.5.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Affymetrix Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Sigma-Aldrich Corp
11.3 Thermo Fisher Scientific Inc.
11.4 Bio-Rad Laboratories, Inc.
11.5 Danaher Corporation
11.6 Agilent Technologies, Inc.
11.7 Merck KGaA
11.8 Luminex Corporation
11.9 MRM Proteomics Inc.
11.10 Waters Corporation
11.11 GE Healthcare
11.12 Bruker Corporation
11.13 Caprion Proteomics Inc.
11.14 PerkinElmer, Inc.
11.15 Genzyme Corporation
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Technology 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecasting by Services 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
12.1.5 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 13Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
